Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37469401)

  • 1. Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy.
    Wei YG; Su H; Lv ZL; Liao XW; Zeng ZM; Jia YX; Huang HS; Shen XQ; Zhu GZ; Han CY; Ye XP; Peng T
    Front Oncol; 2023; 13():1165538. PubMed ID: 37469401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review.
    Labadie KP; Schaub SK; Khorsand D; Johnson G; Apisarnthanarax S; Park JO
    World J Hepatol; 2019 Jan; 11(1):119-126. PubMed ID: 30705724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
    Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
    Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report.
    Chen J; Liao X; Wu Y; Ou S; Qin W; Yang C; Tan Y; Lao Q; Peng M; Peng T; Ye X
    Pharmgenomics Pers Med; 2023; 16():949-958. PubMed ID: 37933333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
    Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.
    Kim HY; Kim JD; Bae SH; Park JY; Han KH; Woo HY; Choi JY; Yoon SK; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH;
    Korean J Hepatol; 2010 Dec; 16(4):355-61. PubMed ID: 21415578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of bilobar multiple hepatocellular carcinoma in which complete remission was achieved by preoperative percutaneous isolated hepatic perfusion and subsequent hepatectomy].
    Urade T; Tanaka M; Fukumoto T; Kido M; Tsuchida S; Takahashi M; Takebe A; Kuramitsu K; Awazu M; Chuma M; Fukushima K; So S; Tai K; Fujimoto M; Toyama H; Shinzeki M; Matsumoto I; Ajiki T; Ku Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1825-7. PubMed ID: 23267899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature.
    Chu JH; Huang LY; Wang YR; Li J; Han SL; Xi H; Gao WX; Cui YY; Qian MP
    World J Gastrointest Oncol; 2024 Apr; 16(4):1647-1659. PubMed ID: 38660668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of transarterial chemoembolization/hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor is effective against hepatocellular carcinoma with portal vein tumor thrombus: A systematic review.
    Yuanren G; Yin L; Liu R; Cui Y
    Front Oncol; 2023; 13():1054072. PubMed ID: 36969065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.
    Chen K; Luo CP; Ge DX; Wang KL; Luo Q; Li YZ; You XM; Xiang BD; Li LQ; Ma L; Zhong JH
    Front Oncol; 2022; 12():946693. PubMed ID: 36276151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment of Large Hepatocellular Carcinoma.
    Chen B; Dai H; Yang J; Zhang G; Wen C; Xiang X; Lin R; Huang Y
    Curr Cancer Drug Targets; 2023; 23(7):564-571. PubMed ID: 36790005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report.
    Shiraishi J; Itoh S; Tomino T; Yoshiya S; Nagao Y; Morita K; Kayashima H; Harada N; Ichiki Y; Yoshizumi T
    J Surg Case Rep; 2023 Aug; 2023(8):rjad485. PubMed ID: 37645700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis.
    Si T; Huang Z; Khorsandi SE; Ma Y; Heaton N
    Front Bioeng Biotechnol; 2022; 10():1010824. PubMed ID: 36237208
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic Survival Factors of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Rohan T; Uher M; Matkulčík P; Zavadil J; Ostřížková L; Kiss I; Andrašina T; Válek V
    Klin Onkol; 2020; 33(3):214-219. PubMed ID: 32683878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of preoperative percutaneous isolated hepatic perfusion and hepatectomy in multidisciplinary treatment].
    Yoshida T; Kido M; Fukumoto T; Komatsu S; Takahashi M; Takebe A; Tanaka M; Kuramitsu K; Kinoshita H; Ajiki T; Matsumoto I; Shinzeki M; Okazaki T; Asari S; Ku Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1822-4. PubMed ID: 24393934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion chemotherapy with implantable arterial access port for advanced-stage hepatocellular carcinoma: a case report.
    Jiang X; Aljbri A; Liu J; Shang L; Tian Y; Shao H
    Front Oncol; 2024; 14():1401882. PubMed ID: 38817896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.